Skip to Main Content

Over the past few years, a pack of sleek, marketing-savvy startups have sprouted up offering online prescriptions for drugs for common medical conditions. But even as they’ve touted their rapid growth, they’ve provided few details about their financials — which they’re entitled to do, as privately held companies.

That changed on Thursday, when San Francisco-based Hims & Hers, one of the leaders in the online pharmacy space, filed paperwork with the Securities and Exchange Commission to go public — shining light for the first time on the detailed financials of a business in an emerging sector that’s transformed the way many people get their medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!